AstraZeneca discontinues Phase 3 trial of Truqap in metastatic castration-resistant prostate cancer Ruchika Sharma30 April 2025 12:14 PM ISTTruqap was discovered by AstraZeneca subsequent to a collaboration with Astex Therapeutics.
Bayer partner seeks approval for Darolutamide plus androgen deprivation therapy for metastatic hormone sensitive prostate cancer Ruchika Sharma8 Jan 2025 12:30 PM ISTOrion's collaboration partner Bayer has submitted an application to the Center of Drug Evaluation (CDE) of China's National Medical Products...
Venus Remedies secures marketing nod from Israel, Colombia for two oncology drugs Ruchika Sharma29 Dec 2023 2:30 PM ISTChandigarh: Building on its international presence in the oncology space, Venus Remedies, has secured marketing authorisation for docetaxel from...
Merck announces positive results from phase 2 trial evaluating coformulation of vibostolimab, pembrolizumab in lung cancer patients Ruchika Sharma10 Dec 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced full results from the non-registrational Phase 2 KeyVibe-002...
Add on Docetaxel Improves Survival for Low-PSA Prostate Cancer Patients: JAMA Jacinthlyn Sylvia15 Nov 2023 6:30 PM ISTA recent study published in Journal of American Medical Association suggests that adding docetaxel to standard treatment could significantly improve...
Medical Bulletin 04/November/2023 Isra Zaman4 Nov 2023 3:30 PM ISTHere are the top medical news of the day:Is frequent mobile phone use linked to reduced sperm quality in young men? Swiss study findsA nationwide...
Docetaxel use associated with significant reduction in prostate cancer death Isra Zaman4 Nov 2023 9:15 AM ISTIn a new study, investigators from Brigham and Women's Hospital, a meta-analysis of five prospective randomized clinical trials (RCTs) found that...
Venus Remedies secures marketing authorisation for key cancer drugs from Philippines, Paraguay, Georgia and Moldova Ruchika Sharma31 July 2023 4:30 PM ISTBangalore: Building up on its sizeable global presence in the oncology space, Venus Remedies Ltd, a well-known provider of affordable cancer drugs...
Venus Remedies secures Saudi marketing approval for chemotherapy drug Docetaxel Ruchika Sharma3 Jun 2023 10:00 AM ISTMumbai: Venus Remedies Ltd has secured a marketing authorisation from the largest market in the Gulf Cooperation Council (GCC) region for...
Bayer gets EU approval for Nubeqa for additional indication in prostate cancer Ruchika Sharma5 March 2023 1:00 PM ISTNubeqa is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.
Venus Remedies bags marketing nod for generic cancer drugs from Uzbekistan, Palestine Ruchika Sharma22 Feb 2023 3:30 PM ISTMumbai: Venus Remedies Limited has received marketing authorisations for its generic cancer drugs from Uzbekistan and Palestine. Having over 800...
Rare case of Serpentine Supravenous Hyperpigmentation reported in NEJM Dr. Kamal Kant Kohli22 Dec 2022 8:00 PM ISTDr Nadine S. Maalouf and Dr Meggie Morand at Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada have reported a rare case of...
